ACS, Yosemite establish $13.2M research grant program

ARPA-H’s Andrew Carney: Join the AI Cyber Challenge to counter cyberattacks on health systems

Can AI-enabled technology safeguard hospitals, pharmacies, and medical devices from cyberattacks?

April 26, 2024

mRNA biomarkers and AI algorithm detect colorectal cancer

Topline results from a pooled clinical study show that Mainz Biomed’s portfolio of proprietary novel gene expression (mRNA) biomarkers can be used in a next generation version of the company’s colorectal cancer screening tool. The study included new patients and subjects from Mainz Biomed’s ColoFuture (Europe) and eAArly DETECT (U.S.) clinical trials. The topline results confirm the positive efficacy results previously reported with a sensitivity for colorectal cancer of 92% with a specificity of 90% and a sensitivity for advanced adenoma of 82%, the company said.

April 26, 2024

Vol.50 No.17

In Brief

Andrew Smith named chair of St. Jude Diagnostic Imaging Department

Andrew Smith was named chair of St. Jude’s Diagnostic Imaging Department. He succeeds Beth McCarville, who was interim chair of the department since the death of Zoltan Patay, who held the position from 2017 to 2022.

April 19, 2024

Vol.50 No.16

Drugs & Targets

COTA and Sanofi collaborate to accelerate cancer trials using real-world data and AI

COTA, a leader in real-world data and analytics for oncology, is entering a collaboration with Sanofi to use RWD and artificial intelligence to increase the speed of oncology trials, including for multiple myeloma.

April 19, 2024

Vol.50 No.16

NCI Director's Report

Rathmell: To improve funding outlook, we must reverse distrust in science

With NCI funding expected to remain flat through fiscal year 2025, health professionals and leaders in oncology should use this time to amp up institutional efforts to collaborate and rebuild trust in science, NCI Director Kimryn Rathmell said.

April 12, 2024

Vol.50 No.15

By Matthew Bin Han Ong

Funding Opportunities

DOD Lung Cancer Research Program funding opportunities for FY24

The FY24 Defense Appropriations Act provides funding for the LCRP to support innovative, high-impact lung cancer research. The managing agent for the anticipated funding opportunities is the CDMRP at the U.S. Army Medical Research and Development Command.

April 12, 2024

Vol.50 No.15

ACS, Yosemite establish $13.2M research grant program

YOU MAY BE INTERESTED IN

ARPA-H’s Andrew Carney: Join the AI Cyber Challenge to counter cyberattacks on health systems

mRNA biomarkers and AI algorithm detect colorectal cancer

Andrew Smith named chair of St. Jude Diagnostic Imaging Department

COTA and Sanofi collaborate to accelerate cancer trials using real-world data and AI

Rathmell: To improve funding outlook, we must reverse distrust in science

DOD Lung Cancer Research Program funding opportunities for FY24

Renew today!

Subscriber content

Login